Samsung's Galaxy Watch6 has demonstrated the ability to predict fainting episodes up to five minutes before they occur, leveraging artificial intelligence and biosensors. This innovative feature focuses on vasovagal syncope (VVS), a common condition that can lead to sudden loss of consciousness.
How the Prediction Works
The Galaxy Watch6 employs photoplethysmography (PPG) sensors to monitor blood volume changes in the skin. AI algorithms analyze these signals to detect patterns preceding a VVS episode. In clinical testing, the system achieved an 84.6% accuracy rate in predicting fainting up to five minutes in advance.
Clinical Validation
A study conducted at Chung-Ang University Gwangmyeong Hospital involving 132 patients validated the technology. The results showed a sensitivity of 90% and specificity of 64%, indicating strong detection capabilities with a moderate false positive rate.
Health Impact
Early warnings could significantly reduce secondary injuries such as fractures or concussions by allowing users to sit down, seek assistance, or move to a safe environment before fainting. This is particularly beneficial for individuals with recurrent VVS.
Prevalence of Vasovagal Syncope
Up to 40% of people experience vasovagal syncope at least once in their lifetime, and about one-third suffer from recurrent episodes. The condition is often triggered by stress, pain, or prolonged standing.
Future Rollout
Samsung plans to pursue regulatory approval for the feature and integrate it into the Galaxy Watch6 and future models after further testing. The company aims to make the tool widely available to enhance user safety.
